Duke University researchers have identified a common mechanism underlying separate forms of dystonia, a family of brain disorders that cause involuntary, debilitating and often painful movements, ...
BOSTON--(BUSINESS WIRE)--CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform, today announced it has raised ...
Discover advancements in assay development and cell-based screening models with insights on AI, high-throughput screening, and toxicity detection from ELRIG Drug Discovery posters in this eBook.
Single B-cell technologies have emerged as powerful screening tools to accelerate antibody discovery, offering R&D teams the potential to interrogate millions of individual antibody-secreting cells to ...
Hosted on MSN
Enhanced CAR T cells emerge from genetic screening
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced its participation in the 21 st Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the ...
Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback